[1]
I. K. Sari, F. Bostan, and C. Çevik, “Effects of spironolactone on calcium and parathyroid hormone in polycystic ovary syndrome”, Exp Biomed Res, vol. 7, no. 2, pp. 49–57, Mar. 2024.